Related Experiment Video
Updated: Dec 8, 2025
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
24.7K
Pharmacogenetics of Type 2 Diabetes-Progress and Prospects
Yulia A Nasykhova1,2, Ziravard N Tonyan1, Anastasiia A Mikhailova1,2
1Department of Genomic Medicine, D.O. Ott's Institute of Obstetrics, Gynecology and Reproductology, 199034 Saint-Petersburg, Russia.
International Journal of Molecular Sciences
|September 23, 2020
Summary
Genetic factors influence how individuals respond to type 2 diabetes (T2D) medications. Understanding these pharmacogenetic variations is key to developing personalized treatment algorithms for this growing global epidemic.
Area of Science:
- Pharmacogenetics
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2D) is a global epidemic characterized by insulin resistance and impaired insulin secretion.
- T2D leads to hyperglycemia, dyslipidemia, hyperinsulinemia, and pancreatic beta-cell dysfunction.
- Significant inter-individual variability exists in T2D drug responses.
Purpose of the Study:
- To summarize recent advances in T2D pharmacogenetics.
- To discuss limitations in current genetic variability knowledge for T2D therapy.
- To explore opportunities for improving personalized T2D treatment.
Main Methods:
- Review of current literature on T2D pharmacogenetics.
- Analysis of genetic factors influencing T2D drug efficacy.
- Discussion of challenges in pharmacogenetic research.
Main Results:
- Genetic factors contribute to variable responses to T2D medications (e.g., biguanides, sulfonylureas, DPP-4 inhibitors, GLP1R agonists, SGLT-2 inhibitors).
- Pharmacogenetics offers insights into disease mechanisms and potential new drug targets.
- Accumulating genetic variability data is crucial for advancing personalized medicine.
Conclusions:
- Pharmacogenetic insights are vital for understanding T2D pathophysiology.
- Further research into genetic variability can optimize T2D drug selection and dosage.
- Personalized treatment strategies hold promise for managing the T2D epidemic.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
01:15Diabetes: Management and Pharmacotherapy
762
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
762
01:36Carbohydrate Metabolism
13.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.2K
01:20Pathophysiology of Diabetes
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.8K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K